NCT06075628 Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry
| NCT ID | NCT06075628 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kansas City Heart Rhythm Research Foundation |
| Condition | Atrial Fibrillation |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-07-24 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-07-24 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is intended to assess the incidence and correlation to the development of peri-device leaks (PDLs), device related thrombosis (DRTs) and cerebral vascular accident (CVA)/transient ischemic attacks (TIAs) in association with left atrial appendage contrast flow (LAA-CF). It will be a multi-center, retrospective study. Approximately 100 subject charts will be reviewed.
Eligibility Criteria
Inclusion Criteria: * Subjects must be at least 18 years of age. * Subjects underwent LAA closure with Watchman/Watchman FLX or Amplatzer Amulet at our institution from January 2019 till June 2022 Exclusion Criteria: * No definite exclusion criteria are defined for the study as all patients with Watchman-FLX or Amplatzer Amulet will be included in the study.
Contact & Investigator
Dhanunjaya Lakkireddy, MD
PRINCIPAL INVESTIGATOR
Kansas City Heart Rhythm Institute
Frequently Asked Questions
Who can join the NCT06075628 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atrial Fibrillation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06075628 currently recruiting?
Yes, NCT06075628 is actively recruiting participants. Contact the research team at datkins@kchrf.com for enrollment information.
Where is the NCT06075628 trial being conducted?
This trial is being conducted at Overland Park, United States.
Who is sponsoring the NCT06075628 clinical trial?
NCT06075628 is sponsored by Kansas City Heart Rhythm Research Foundation. The principal investigator is Dhanunjaya Lakkireddy, MD at Kansas City Heart Rhythm Institute. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.